DOJ Eyes AtriCure Over Marketing Practices
The West Chester, Ohio-based AtriCure said Friday it had received a letter on Oct. 27 informing the company that the DOJ’s Civil Division was conducting an investigation for potential False Claims Act and common law violations.
The probe relates to AtriCure’s devices for surgical ablation, a procedure that renders abnormal areas of heart tissue ineffective in order to ensure that the patient’s...
To view the full article, register now.
Try Law360 FREE for seven days
Already a subscriber? Click here to login